Food and Drugs Act, R.S.C. 1985, c. F-27
Section 21.91
Additions to Schedule G
Cite as Food and Drugs Act, R.S.C. 1985, c. F-27, s. 21.91 · current to July 24, 2025 · Act last amended March 27, 2025
Statute Watch
Get an alert when a bill in Parliament would change this section, and every time it moves.
The text
(1) For the purpose of preventing injury to health or preventing a person from being deceived or misled, the Minister may, by order, add a description of a therapeutic product or a class of therapeutic products to Schedule G if the Minister believes that the therapeutic product or products represent an emerging or innovative technological, scientific or medical development.
(2) Before adding a description of a therapeutic product or a class of therapeutic products to Schedule G, the Minister shall consider the following factors:
(a) the degree of uncertainty respecting the risks and benefits associated with the therapeutic product or products and the measures that are available to adequately manage and control those risks;
(b) the extent to which the therapeutic product or products are different from therapeutic products for which therapeutic product authorizations have been issued under the regulations;
(c) the extent to which existing legal frameworks are adequate to prevent injury to health or to prevent persons from being deceived or misled; and
(d) the prescribed factors, if any.
(3) The Minister may, by order, delete the description of a therapeutic product or a class of therapeutic products from Schedule G.
Read the Food and Drugs Act on the Justice Laws Website ↗
Bills in Parliament that would change this section 0
No bill we hold would amend or repeal this section.